Gene and cell therapy is booming worldwide, fueled by major innovations in life science and medicine and funding from global capital markets. To advance this crucial field, GenScript convenes top scientists and industry leaders from around the world, concurrent with Jefferies London Healthcare Conference. The upcoming GenScript Biotech Global Forum London 2024 will take place in London on Wednesday, November 20, 2024.
Under the theme Unlock the Full Potential of Cell and Gene Therapies, GenScript is inviting gene and cell therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies to focus on recent developments in research, technological breakthroughs, AI in biopharmaceutical, and regulatory trends. We are looking forward to hosting thought leaders from around the world, united in the pursuit of cures to help more patients.
We would like to extend to you a cordial invitation to join your peers at this important event in London in November 2024.
Dima AI-hadithi, Ph.D.
Director
Minaret Consulting Limited
Karim Benabdellah, Ph.D.
Principal Investigator
GENYO
Qingyu Cao, Ph.D.
Senior Director
Head of European Business Development, ProBio
Kristina Cornish
Partner
Pinsent Masons, London; European and UK Patent Attorney
Vincenzo Di Cerbo, Ph.D.
Lead Technical Scientist
Cell and Gene Therapy Catapult
Ming Ewe
CEO
Smarter Biotech Solutions
Jim Faulkner, Ph.D.
CEO
JDB BioConsulting
Miguel Forte, M.D., Ph.D.
President of International Society for Cell & Gene Therapy (ISCT)
ARM Board Member, Chief Executive Officer of Kiji Therapeutics
Jason Foster
CEO and Executive Director
Ori Biotech
Stephen Hansen
Director of Biopharma Intelligence
BioCentury
Ying Huang, Ph.D.
CEO
Legend Biotech
Reagan Jarvis, Ph.D.
CEO and Co-founder
Anocca
Peter Jones
Director
Pengwin Consultancy
Arindam Mitra
CMC Director
Leucid Bio
Deividas Pazeraitis
Senior Scientist
AstraZeneca
Maelle Quere, Ph.D.
Scientist
Sanofi
Josh Resnick, M.D.
Senior Managing Director
RA Capital Management
Sherry Shao
Rotating CEO
GenScript Biotech Corporation
Ping Shek
Managing Director
Investment Banking Division – Healthcare, Stifel
Kelly Shi, Ph.D.
Senior Vice President
Research Analyst, Jefferies LLC
Pascal Touchon, Ph.D.
Chairman of the Board
Atara Biotherapeutics
James Wilson, M.D., Ph.D.
President and CEO, Gemma Biotherapeutics (GEMMABio); Founder and Advisor – Scout Bio, Passage Bio, iECURE; Executive Chair, Franklin Biolabs
Shawn Wu, Ph.D.
President of European Division,
GenScript Biotech Corporation
Lumeng Ye, Ph.D.
Director of Novel therapeutic materials
R&D Dept, GenScript Biotech Corporation
Biao Zheng, M.D., Ph.D.
CEO
BRL Medicine
116 Pall Mall, St. James's, London SW1Y 5ED,United Kingdom